Alejandro M. Rosique-Valcuende

San Vicent Del Raspeig, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Real-world outcomes of tafamidis in transthyretin amyloid cardiomyopathy.

Real-world outcomes of tafamidis in transthyretin amyloid cardiomyopathy.

Journal: Archivos de cardiologia de Mexico

Published: July 16, 2026

The CONUT Score Independently Predicts Mortality in Older Patients with Hip Fracture.

The CONUT Score Independently Predicts Mortality in Older Patients with Hip Fracture.

Journal: Medicina (Kaunas, Lithuania)

Published: May 28, 2026

Letter to the editor regarding "Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice".

Letter to the editor regarding "Real world effectiveness, persistence, tolerability, and safety of ofatumumab in clinical practice".

Journal: Neurodegenerative disease management

Published: May 24, 2026

Letter to the editor 'high persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study)'.

Letter to the editor 'high persistence and efficacy of ustekinumab as a first-line biological therapy in inflammatory bowel disease: a real-world cohort study)'.

Journal: Scandinavian journal of gastroenterology

Published: April 29, 2026

Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.

Remission and treatment persistence during sequential therapy in rheumatoid arthritis: results from the Estonian Biologic Treatment Registry.

Journal: Rheumatology international

Published: March 27, 2026

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

Comment on: Final results from the vedolizumab extended access program multinational study demonstrate long-term treatment persistence and safety.

Journal: Therapeutic advances in gastroenterology

Published: March 12, 2026

Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study".

Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study".

Journal: Intestinal research

Published: March 03, 2026

Higher anticholinergic burden is associated with increased medium- and long-term mortality following hip fracture: A systematic review and meta-analysis.

Higher anticholinergic burden is associated with increased medium- and long-term mortality following hip fracture: A systematic review and meta-analysis.

Journal: British journal of clinical pharmacology

Published: February 03, 2026

Comment on: Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study.

Comment on: Drug survival, long-term safety and efficacy of anti-TNF-alpha biosimilars: a monocentric retrospective study.

Journal: Italian journal of dermatology and venereology

Published: January 22, 2026

Persistence to palbociclib treatment in HR+/HER2- breast cancer patients: A real-world study.

Persistence to palbociclib treatment in HR+/HER2- breast cancer patients: A real-world study.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: January 14, 2026

Letter to the Editor Regarding 'National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort Study'.

Letter to the Editor Regarding 'National and Regional Drug Survival of Omalizumab in Chronic Spontaneous Urticaria: A Danish Cohort Study'.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: January 04, 2026

Letter to the Editor "Use and Persistence of Beta 3-Adrenoceptor Agonists for the Treatment of Overactive Bladder".

Letter to the Editor "Use and Persistence of Beta 3-Adrenoceptor Agonists for the Treatment of Overactive Bladder".

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 02, 2026

Showing 1-12 of 41

Last Updated: 09/26/2026